4-(4-aminophenyl)morpholin-3-one CAS:211914-50-0

Analgesic and Antipyretic Medications: The compound may have applications in the development of analgesic and antipyretic drugs. Its pharmacological properties could be explored to alleviate pain and reduce fever, making it a candidate for use in medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and antipyretics. Antidepressants and Anxiolytics: This compound may have implications in the development of medications targeting psychiatric disorders. It could be investigated for its potential as an antidepressant or anxiolytic agent, based on its ability to modulate neurotransmitter systems and neural circuits associated with mood and anxiety regulation. Antiemetics: 4-(4-aminophenyl)morpholin-3-one's chemical properties suggest potential applications in the development of antiemetic medications. It may be utilized to mitigate nausea and vomiting, providing relief for patients undergoing chemotherapy, experiencing motion sickness, or suffering from other conditions causing nausea. Cardiovascular Drugs: The compound may exhibit pharmacological properties relevant to cardiovascular medicine. It could be studied for its potential effects on cardiac function, blood pressure regulation, or vascular health, potentially leading to the development of new treatments for cardiovascular diseases such as hypertension or heart failure. Neuroprotective Compounds: Given its chemical structure, the compound could be explored for its neuroprotective properties. Research efforts may focus on its potential to protect neurons from damage or degeneration, making it a candidate for the development of treatments for neurodegenerative diseases such as Alzheimer's or Parkinson's disease. Chemical Biology Tools: 4-(4-aminophenyl)morpholin-3-one can serve as a valuable tool in chemical biology research. It may be utilized to study molecular interactions, cellular signaling pathways, and drug-receptor binding, providing insights into biological processes and serving as a starting point for drug discovery projects. When considering the utilization of 4-(4-aminophenyl)morpholin-3-one in pharmaceutical development, adherence to rigorous safety guidelines, ethical considerations, and regulatory standards is essential. Thorough preclinical and clinical evaluations are necessary to assess its pharmacokinetics, efficacy, and potential adverse effects, ensuring its safe and effective use in various therapeutic applications.